Yüklüyor......
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Insertion mutations in exon 20 (Ex20ins) of the epidermal growth factor receptor (EGFR) gene are the largest class of EGFR mutations in non-small cell lung cancer (NSCLC) for which there are currently no approved targeted therapies. NSCLC patients with these mutations do not respond to clinically ap...
Kaydedildi:
| Yayımlandı: | Pharmgenomics Pers Med |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955704/ https://ncbi.nlm.nih.gov/pubmed/33727854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S242045 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|